Logo

DDD

3D Systems Corporation

DDD

3D Systems Corporation NYSE
$2.08 1.96% (+0.04)

Market Cap $267.78 M
52w High $5.00
52w Low $1.32
Dividend Yield 0%
P/E 52
Volume 814.27K
Outstanding Shares 128.74M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $91.249M $48.405M $-18.053M -19.784% $-0.144 $-13.386M
Q2-2025 $94.838M $51.5M $104.436M 110.12% $0.79 $122.672M
Q1-2025 $94.54M $69.452M $-36.986M -39.122% $-0.28 $-29.119M
Q4-2024 $111.024M $64.813M $-33.707M -30.36% $-0.25 $-22.672M
Q3-2024 $112.94M $222.471M $-178.627M -158.161% $-1.35 $-167.154M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $99.942M $554.549M $331.257M $221.1M
Q2-2025 $116.358M $587.844M $344.405M $241.246M
Q1-2025 $135.04M $583.355M $435.682M $145.639M
Q4-2024 $171.324M $608.846M $430.695M $176.193M
Q3-2024 $190.005M $658.276M $438.151M $218.032M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-18.053M $-13.501M $-4.655M $-1M $-20.815M $-15.753M
Q2-2025 $104.436M $-25.844M $116.343M $-96.691M $-2.266M $-28.792M
Q1-2025 $-36.986M $-33.786M $-3.412M $-649K $-36.669M $-36.581M
Q4-2024 $-33.455M $-7.778M $-5.873M $-518K $-18.692M $-13.101M
Q3-2024 $-178.879M $-801K $-3.647M $-367K $-2.713M $-4.448M

Revenue by Products

Product Q3-2024Q4-2024Q1-2025Q2-2025
Product
Product
$70.00M $70.00M $50.00M $50.00M
Service
Service
$40.00M $40.00M $40.00M $40.00M

Five-Year Company Overview

Income Statement

Income Statement Revenue has been drifting down over the last few years, after a short-lived bump earlier in the period. The company is still generating decent gross margins on what it sells, but those margins are not enough to cover operating costs, so operating results have been in the red most years. Profitability looks inconsistent: there was one clearly profitable year in the middle of the period, surrounded by several years of meaningful losses. Recent years show deeper losses again, which suggests that scale, pricing power, or cost control have not yet been fully resolved. Overall, the income statement tells a story of a company with attractive technology but a business model that has not yet translated into steady, sustainable profits.


Balance Sheet

Balance Sheet The balance sheet has become leaner over time. Total assets and cash were much higher a few years ago and have since come down, likely reflecting a mix of cash burn, divestitures, and write-downs. Debt is above early-period levels and, relative to equity, now plays a more noticeable role in the capital structure. Shareholders’ equity has shrunk from prior peaks as cumulative losses have built up. The company still has resources to operate, but its financial cushion is thinner than it was at its recent high point, leaving less room for prolonged weak performance without further balance-sheet actions.


Cash Flow

Cash Flow Cash flow from day-to-day operations has been slightly negative in most years, with only a brief period of positive cash generation. Free cash flow follows the same pattern, since investment in equipment and facilities has been modest and fairly steady. This means the business has not consistently funded itself from its own operations and has depended on existing cash, asset sales, or financing to bridge the gap. While the cash burn does not appear extreme in any single year, the persistence of weak operating cash flow is an important risk to watch until there is clearer evidence of a durable turnaround in profitability.


Competitive Edge

Competitive Edge 3D Systems remains one of the better-known names in 3D printing, with a long history, a broad patent base, and a wide range of technologies spanning polymers and metals. Its diversified product set and “hardware plus materials and services” model help create recurring relationships with customers. The company has carved out particularly strong positions in healthcare and dental applications, where regulatory know-how, clinical relationships, and specialized workflows create some barriers to entry. At the same time, the overall 3D printing market is crowded, with capable competitors like Stratasys, EOS, HP, and others. Price pressure, rapid technological change, and customers who often use multiple vendors all limit how strong any one player’s moat can be. 3D Systems’ competitive edge is real but not unassailable, and its challenge is to convert its legacy advantages into reliable, profitable growth.


Innovation and R&D

Innovation and R&D Innovation is one of 3D Systems’ clear strengths. The company helped invent core 3D printing technologies and still offers a wide set of processes—SLA, SLS, metal printing, multi-jet printing—and a large materials library. More recently, it has pushed into high-value, specialized areas: bioprinting with partners for organ scaffolds, regenerative tissue programs, and tailored healthcare and dental solutions. These efforts are long-term and high risk, but they also carry the potential for breakthrough value if they succeed. On the software side, the company is refocusing on its 3D Sprint platform and aims to infuse it with artificial intelligence to streamline design-to-production workflows. R&D is clearly being used not just to improve printers, but to build integrated, application-specific solutions. The open question is timing: many of these bets may take years to materially impact revenue and profits, while the company is already under financial pressure.


Summary

3D Systems sits at a crossroads. On one hand, it has a respected brand, deep technical know-how, and ambitious innovation programs in areas like healthcare, bioprinting, and AI-enabled software. Its technology portfolio and installed base give it a credible role in the additive manufacturing ecosystem. On the other hand, recent financial trends show shrinking revenue, recurring losses, and a slimmer balance-sheet cushion than in the past. Cash generation from the core business has been weak, so the company has less room for missteps as it pursues its long-range innovation agenda. How effectively management can stabilize the top line, improve margins, and turn its R&D pipeline into commercially successful, profitable products will largely determine whether the story evolves into a sustainable growth business or remains a technically impressive but financially challenged enterprise.